The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …

Infectious diseases, particularly Tuberculosis (TB) caused by Mycobacterium tuberculosis,
pose a significant global health challenge, with 1.6 million reported deaths in 2021, making …

Early in the COVID-19 pandemic, data suggested that males had a higher risk of developing
severe disease and that androgen deprivation therapy might be associated with protection …

Antisense oligonucleotides (ASOs) are single stranded nucleic acids that target RNA. The
US Food and Drug Administration has approved ASOs for several diseases. ASOs utilize …

Given the worldwide risk for the outbreak of emerging/re-emerging respiratory viruses,
establishment of new antiviral strategies is greatly demanded. In this study, we present a …

Although the COVID-19 pandemic was declared no longer a global emergency by the World
Health Organization in May 2023, SARS-CoV-2 is still infecting people across the world …

Emerging viruses, such as novel influenza A viruses (IAV) and severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), pose a constant threat to animal and human health …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the
coronavirus disease 2019 (COVID-19) pandemic and is continuously spreading globally …

RNA molecules in the cell are bound by a multitude of RNA-binding proteins (RBPs) with a
variety of regulatory consequences. Often, interactions with these RNA-binding proteins are …

Abstract Background The Spike protein mutation of SARS-CoV-2 led to decreased protective
effect of various vaccines and monoclonal antibodies, suggesting that blocking SARS-CoV-2 …